autoantibody
Showing 376 - 397 of 397
Opsoclonus-myoclonus Syndrome, Opsoclonus, Myoclonus Trial in Springfield (rituximab)
Completed
- Opsoclonus-myoclonus Syndrome
- +3 more
-
Springfield, IllinoisNational Pediatric Myoclonus Center, Department of Neurology, SI
May 6, 2011
Rheumatoid Arthritis Trial in Worldwide (Abatacept, Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD), Anti-Tumor
Type 1 Diabetes Trial in Winnipeg (vitamin D3)
Completed
- Type 1 Diabetes
- vitamin D3
-
Winnipeg, Manitoba, CanadaManitoba Institute of Child Health
Apr 25, 2011
Rheumatoid Arthritis Trial in United States (Abatacept, Placebo)
Vasomotor Symptoms Trial in Canada, United States (desvenlafaxine succinate (DVS) SR, Placebo)
Completed
- Vasomotor Symptoms
- desvenlafaxine succinate (DVS) SR
- Placebo
-
Birmingham, Alabama
- +120 more
Jul 21, 2011
Diabetes, Autoimmune, Diabetes, Adult-Onset Trial (Insulin)
Completed
- Diabetes, Autoimmune
- Diabetes Mellitus, Adult-Onset
- (no location specified)
Apr 22, 2010
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases
Unknown status
- SLE
- +2 more
-
Taipei, Taiwan, TaiwanChung-Yi Hu
May 20, 2010
+Significance of Paraneoplastic Autoantibodies in Many Cancers
Completed
- Lung Cancer
- +4 more
- Symptom Assessment Scale
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 12, 2009
Rheumatoid Arthritis, Polyarthritis Trial in Glasgow (Musculoskeletal Ultrasound, 28 Joint Disease Activity Score)
Unknown status
- Rheumatoid Arthritis
- Polyarthritis
- Musculoskeletal Ultrasound
- 28 Joint Disease Activity Score
-
Glasgow, United Kingdom
- +2 more
Sep 9, 2009
Lupus Erythematosus, Systemic, Lupus Nephritis Trial in Austria, Germany, Netherlands (infliximab, )
Terminated
- Lupus Erythematosus, Systemic
- Lupus Nephritis
- infliximab
- placebo
-
Graz, Austria
- +8 more
Oct 2, 2009
Lupus Nephritis Trial in Fuzhou (mesenchymal stem cell)
Unknown status
- Lupus Nephritis
- mesenchymal stem cell
-
Fuzhou, Fujian, ChinaFuzhou General Hospital
Apr 14, 2008
Lacrimal Apparatus Disease, Salivary Gland Disease, Sjogren's Syndrome Trial run by the NIDCR (Dehydroepiandrosterone)
Completed
- Lacrimal Apparatus Disease
- +3 more
-
Bethesda, MarylandNational Institute of Dental And Craniofacial Research (NIDCR)
Mar 3, 2008
Vasculitis, Wegener's Granulomatosis Trial run by the NIAID (Mycophenolate Mofetil)
Completed
- Vasculitis
- Wegener's Granulomatosis
- Mycophenolate Mofetil
-
Bethesda, MarylandNational Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008
Glomerulonephritis, Membranoproliferative, Lupus Nephritis Trial run by the NIAMS (BG9588)
Completed
- Glomerulonephritis, Membranoproliferative
- Lupus Nephritis
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Mar 3, 2008
Antibodies in Cognitive Dysfunction in Systemic Lupus
Completed
- Systemic Lupus Erythematosus
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Mar 3, 2008
Renal Failure, Chronic, Renal Transplantation Trial in Giessen (intravenous immunoglobulins (IVIG), kidney transplantation)
Completed
- Renal Failure, Chronic
- Renal Transplantation
- intravenous immunoglobulins (IVIG)
- kidney transplantation
-
Giessen, GermanyDepartment of Internal Medicine, University of Giessen
May 8, 2007
Diabetes, Type 1, Diabetes, Type 2 Trial in Jinan (Autologous bone marrow mononuclear cell transplantation)
Unknown status
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Autologous bone marrow mononuclear cell transplantation
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Apr 24, 2007
Hypertension Trial in Wuhan (candesartan cilexetil)
Unknown status
- Hypertension
- candesartan cilexetil
-
Wuhan, Hubei, ChinaDepartment of Cardiology, Wuhan Union Hospital
Aug 4, 2006
Characterization of Macroprolactinemia
Completed
- Hyperprolactinemia
-
Osaka, JapanKansai Medical University
Feb 15, 2007
Systemic Lupus Erythematosus Trial in Mexico (Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d)
Completed
- Systemic Lupus Erythematosus
- Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
-
Mexico, MexicoI
Oct 23, 2006
Decoy Receptor 3 Polymorphisms in Rheumatoid Arthritis and
Unknown status
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
-
Taipei, TaiwanChung-Yi Hu
Mar 29, 2006